Clinical Trial Update: ROMANCE: "Irinotecan Plus Cetuximab Rechallenge Versus Trifluridine/Tipiracil Plus Bevacizumab in Molecularly Selected Metastatic Colorectal Cancer" [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing irinotecan plus cetuximab rechallenge versus trifluridine/tipiracil plus bevacizumab in molecularly selected metastatic colorec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Gruppo Oncologico Italia Meridionale | Conditions: Metastatic Colorectal Cancer (CRC) | Phase 2 | Status: NOT_YET_RECRUITING